Fulcrum Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 03, 2023 at 07:11 am
Fulcrum Therapeutics, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 23.78 million compared to USD 34.07 million a year ago. Basic loss per share from continuing operations was USD 0.38 compared to USD 0.83 a year ago.
For the six months, net loss was USD 48.56 million compared to USD 60 million a year ago. Basic loss per share from continuing operations was USD 0.8 compared to USD 1.47 a year ago.